XENON PHARMACEUTICALS INC. <XENE.O>: LEERINK PARTNERS CUTS TARGET PRICE TO $60 FROM $70

Reuters2026/10/08 11:09

By:Reuters

XENON PHARMACEUTICALS INC. : LEERINK PARTNERS CUTS TARGET PRICE TO $60 FROM $70

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

You may also like

Asian Stocks Rebound, Nikkei Up 3.4%, but Can They Lead Wall Street?

BeInCrypto•2026/11/09 03:21

Brent Crude Fell 12.5% But Former Biden Advisor Warns Iran War Could Return

BeInCrypto•2026/11/09 02:39

Cathie Wood Blames Anthropic’s CEO for AI Panic: Why Attack a Company Her Fund Backs?

BeInCrypto•2026/11/08 22:24

Anthropic's $1.5 Trillion IPO: What Investors Should Know Before Buying

BeInCrypto•2026/11/08 14:42